Immunoproteomics reveals that cancer of the tongue and the gingivobuccal complex exhibit differential autoantibody response

Cancer Biomarkers

Volumn 5, Issue 3, 2009, Pages 127-135

  Shukla, Sanjeev ^a   Pranay, Atul ^a   D'Cruz, Anil K ^a   Chaturvedi, Pankaj ^a   Kane, Shubhada V ^a   Zingde, Surekha M ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Autoantibodies; Gingivo buccal complex; Immunoproteomics; Tongue; Tumor antigen

Indexed keywords

ALDEHYDE REDUCTASE; ALPHA ENOLASE; ALPHA TUBULIN; AUTOANTIBODY; BETA TUBULIN; HEAT SHOCK PROTEIN 70; LIPOCORTIN 2; PEROXIREDOXIN 6; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PYRUVATE KINASE; TRIOSEPHOSPHATE ISOMERASE;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CANCER LOCALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME ASSAY; FEMALE; GINGIVA TUMOR; GINGIVOBUCCAL COMPLEX CANCER; HUMAN; HUMAN CELL; IMMUNOASSAY; MALE; MOUTH CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEOMICS; TISSUE SPECIFICITY; TONGUE CANCER;

ADULT; AGED; ALDEHYDE REDUCTASE; AMINO ACID SEQUENCE; ANNEXIN A2; AUTOANTIBODIES; BLOOD PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GINGIVAL NEOPLASMS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MOUTH NEOPLASMS; PEROXIREDOXIN VI; PHOSPHOPYRUVATE HYDRATASE; PROTEOMICS; PROTON-TRANSLOCATING ATPASES; PYRUVATE KINASE; TRIOSE-PHOSPHATE ISOMERASE; TUBULIN;

EID: 65449142776     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/CBM-2009-0604     Document Type: Article

References (27)

1. K.S. Anderson and J. LaBaer, The sentinel within: Exploiting the immune system for cancer biomarkers, J Proteome Res 4(4) (2005), 1123-1133.
2. Y.S. Cho-Chung, Autoantibody biomarkers in the detection of cancer, Biochim Biophys Acta 1762(6) (2006), 587-591.
3. M. Nesterova et al., Autoantibody biomarker opens a new gateway for cancer diagnosis, Biochim Biophys Acta 1762(4) (2006), 398-403.
4. S.H. Shoshan and A. Admon, Novel technologies for cancer biomarker discovery: Humoral proteomics, Cancer Biomark 3(3) (2007), 141-152.
5. M. Caron, G. Choquet-Kastylevsky and R. Joubert-Caron, Cancer immunomics using autoantibody signatures for biomarker discovery, Mol Cell Proteomics 6(7) (2007), 1115-1122.
6. S.R. Pereira-Faca et al., Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer, Cancer Res 67 24) (2007), 12000-12006.
7. L. Li et al., Identification of hepatocellular-carcinomaassociated antigens and autoantibodies by serological proteome analysis combined with protein microarray, J Proteome Res 7(2) (2008), 611-620.
8. B.S. Taylor et al., Humoral response profiling reveals pathways to prostate cancer progression, Mol Cell Proteomics 7(3) (2008), 600-611.
9. A. Gagnon et al., Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients, Clin Cancer Res 14 3) (2008), 764-771.
10. S. Shukla et al., Tumor antigens elciting autoantibody response in cancer of gingivo-buccal complex, Proteomics Clinical Applications 1(12) (2007), 1592-1604.
11. C.A. Squier and M.J. Kremer, Biology of oral mucosa and esophagus, J Natl Cancer Inst Monogr (29) (2001), 7-15.
12. D.M. Walker, Oral mucosal immunology: An overview, Ann Acad Med Singapore 33 (2004), 27S-30S.
13. S.R. Moore et al., The epidemiology of tongue cancer: A review of global incidence, Oral Dis 6(2) (2000), 75-84.
14. T.A. Winning and G.C. Townsend, Oral mucosal embryology and histology, Clin Dermatol 18(5) (2000), 499-511.
15. K.M. Sathyan et al., Carcinoma of tongue and the buccal mucosa represent different biological subentities of the oral carcinoma, J Cancer Res Clin Oncol 132(9) (2006), 601-609.
16. J. Chen et al., Proteomics of buccal squamous cell carcinoma: The involvement of multiple pathways in tumorigenesis, Proteomics 4 8) (2004), 2465-2475.
17. Q.Y. He et al., Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics, Proteomics 4 1) (2004), 271-278.
18. H. Schliephake, Prognostic relevance of molecular markers of oral cancer - a review, Int J Oral Maxillofac Surg 32(3) (2003), 233-245.
19. J. Kaur, A. Srivastava and R. Ralhan, Serum p53 antibodies in patients with oral lesions: Correlation with p53/HSP70 complexes, Int J Cancer 74(6) (1997), 609-613.
20. R. Ralhan et al., Circulating p53 antibodies as early markers of oral cancer: Correlation with p53 alterations, Clin Cancer Res 4 9) (1998), 2147-2152.
21. M. Castelli et al., Anti-p53 and anti-heat shock proteins antibodies in patients with malignant or pre-malignant lesions of the oral cavity, Anticancer Res 21(1B) (2001), 753-758.
22. R. Murase et al., Serum autoantibody to sideroflexin 3 as a novel tumor marker for oral squamous cell carcinoma, Proteomics Clinical Applications 2 (2008), 517-527.
23. O. Gires et al., Profile identification of disease-associated humoral antigens using AMIDA, a novel proteomics-based technology, Cell Mol Life Sci 61(10) (2004), 1198-1207.
24. H.S. Lin et al., Autoantibody approach for serum-based detection of head and neck cancer, Cancer Epidemiol Biomarkers Prev 16(11) (2007), 2396-2405.
25. G. Peterson, A simplification of the protein assay method of Lowry, et al which is more generally applicable, Anal Biochem 83 (1977), 346-356.
26. O.H. Lowry et al., Protein measurement with the Folin phenol reagent, J Biol Chem 193(1) (1951), 265-275.
27. U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227(5259) (1970), 680-685.